WRAPITIS: Chest and Abdominal Wall Strapping in Infant With Bronchiolitis

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06083077
Collaborator
(none)
23
1
1
25
0.9

Study Details

Study Description

Brief Summary

Bronchiolitis is the most common cause of admission to the Paediatric Intensive Care Unit (PICU) for respiratory distress.

The care of an infant with severe bronchiolitis is mainly based on symptomatic treatment (nutritional and respiratory support). The lower part of an infant's chest is larger than that of an older child, which can flatten the diaphragm, especially in obstructive disease with air trapping. Strapping the lower part (at the junction of the chest and abdomen) may provide a better condition for diaphragmatic contraction. Based on respiratory mechanics in infants and physiological studies in adults, investigators hypothesise that chest wall strapping may improve the ventilation and the diaphragmatic contraction.

Infant < 6 month with severe bronchiolitis admitted to the PICU will be recorded in 4 conditions with or without chest wall strapping and with a Continuous Positive Airway Pressure (CPAP) at 7 cmH2O or without CPAP. Physiological parameters (including work of breathing, respiratory parameters, distribution of ventilation) will be recorded and analysed.

Condition or Disease Intervention/Treatment Phase
  • Other: Chest wall strapping
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
23 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Infant will be recorded successively in 6 conditions (10 min each) : Without chest wall strapping at PEEP (Positive End Expiratory Pressure) 0 and PEEP 7 With chest wall strapping at PEEP 0 and PEEP 7 again without chest wall strapping at PEEP 0 and PEEP 7.Infant will be recorded successively in 6 conditions (10 min each) :Without chest wall strapping at PEEP (Positive End Expiratory Pressure) 0 and PEEP 7 With chest wall strapping at PEEP 0 and PEEP 7 again without chest wall strapping at PEEP 0 and PEEP 7.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Chest and Abdominal Wall Strapping on Ventilation and Work of Breathing in Infants With Severe Bronchiolitis: a Physiological Study
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2025
Anticipated Study Completion Date :
Nov 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Infant < 6 months with severe bronchiolitis

Infant will be recorded successively in 6 conditions (10 min each) : Without chest wall strapping at PEEP 0 and PEEP 7 With chest wall strapping at PEEP 0 and PEEP 7 again without chest wall strapping at PEEP 0 and PEEP 7.

Other: Chest wall strapping
An elastic band (6 cm wide) is placed around the lower part of the chest wall (at the junction of the chest and abdomen) to tighten the chest wall for 10 min at PEEP 7 cmH2O and 10 min without PEEP

Outcome Measures

Primary Outcome Measures

  1. Esophagal product time pressure [1 hour]

    Average over 100 consecutive cycles of esophageal product time pressure value

Secondary Outcome Measures

  1. Diaphragmatic product time pressure [1 hour]

    Average over 100 consecutive cycles of diaphragmatic product time pressure value

  2. Esophagal and diaphragmatic swing [1 hour]

    Mean on 100 breaths of the amplitude (maximum value -minimum value) of the esophageal pressure (cmH2O) and gastric pressure (cmH2O)

  3. Distribution of ventilation : center of ventilation [1 hour]

    Mean over 1 minute of the center of the ventilation (%). Center of ventilation represents the average of the dorsal-ventral distribution of tidal variation using Electrical Impedance Tomography (values >50% indicating that the center of ventilation is located in the ventral part of the chest)

  4. End expiratory lung volume [1 hour]

    Average over 1 minute of the end expiratory lung impedance

  5. Time ratio [1 hour]

    average over 100 consecutive cycles of inspiratory to aspiratory time ratio

  6. modified wood asthma score (mWCAS) [1 hour]

    Value of the modified wood asthma score at the end of the recording period in each condition. Minimal value 0 and maximal value 10. A score ≥ 3 mean a moderate-to-severe respiratory distress.

  7. TcPCO2 [1 hour]

    Average of the transcutaneous CO2 (carbon dioxide) partial over 1 minute

  8. EDIN scale (Newborn Pain and Discomfort Scale) [1 hour]

    Value of the EDIN score at the end of the recording period in each condition. Minimal value 0 and maximal value 15. EDIN scores > 6 are considered expression of pain

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 6 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Infant < 6 months

  • Admitted to the PICU for less than 48 hours

  • With a diagnosis of bronchiolitis

  • With a respiratory distress sign (mWCAS ≥ 3) and non-invasive ventilatory support

  • With a naso or oro gastric tube for feeding

  • With written informed consent from parents or legal guardians

Exclusion Criteria:
  • Infants with severe bronchopulmonary disease, severe laryngomalacia, neuromuscular disease, bone disease, cyanotic heart disease

  • Contraindication to the use of a gastric tube

  • recent abdominal or thoracic surgery

  • investigator able to perform physiological recording not available

  • Patient who is not affiliated (or does not benefit from) to a national social security system

Contacts and Locations

Locations

Site City State Country Postal Code
1 Réanimation pédiatrique Bron France 69500

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT06083077
Other Study ID Numbers:
  • 69HCL23_0821
First Posted:
Oct 13, 2023
Last Update Posted:
Oct 13, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospices Civils de Lyon
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 13, 2023